Prof. Albert Rizvanov graduated from Kazan State University, Russia (biology, microbiology) in 1996. After completing his Ph.D. (2003) in cellular and molecular biology at the University of Nevada, Reno, USA, he undertook his Dr.Sci. (2011) in biochemistry (Habilitation) at Kazan Federal University (KFU), Russia. Currently, he is a Professor at the Department of Genetics and Head of the Center of Excellence "Personalized Medicine", Institute of Fundamental Medicine and Biology, KFU. He is the head of the OpenLab Gene and Cell Technologies Laboratory and Director of the Department of Exploratory Researches of Pharmaceutical Research and Education Center. He is the principal investigator of numerous projects, with more than 60 grants supported by NATO, the British Council, the Russian Science Foundation, the Russian Foundation for Basic Research, and other Russian government federal programs and industry contracts. His fields of expertise include regenerative medicine, precision medicine, gene and cell therapy, molecular neurobiology, molecular virology, cancer diagnostics, and therapy. From 2019 to 2021, he was an honorary professor at the Faculty of Medicine and Health Sciences, University of Nottingham, UK. Prof. Albert Rizvanov is a corresponding member and Academician-Secretary of the Division of Medical and Biological Sciences of the Tatarstan Academy of Sciences.